Logo Logo
Banner

17β-HSD10-IN-2

Products
Online Inquiry

Please note that we are a research service provider and do not offer diagnostic or therapeutic services for patients.

17β-HSD10-IN-2

Cat. No. NATM-2505-CXX-14

Package 50 mg/100 mg/250 mg

Datasheet

Description

17β-HSD10-IN-2 (compound 11) is a benzothiazolylurea-based inhibitor targeting 17β-hydroxysteroid dehydrogenase type 10 (17β-HSD10), a multifunctional mitochondrial enzyme. It has no mitochondrial off-target, cytotoxic, or neurotoxic effects. 17β-HSD10 inhibitors are useful for Alzheimer's disease (AD) and hormone-dependent cancer research.

Product Details

Formula C15H10ClN3O4S
Molecular Weight 363.78
SMILES O=C(NC1=CC=C(C(Cl)=C1)O)NC2=NC3=CC=C(C(O)=O)C=C3S2
Biological Target Endogenous Metabolite
Target 17β-HSD10
Initial Source Endogenous metabolite
Shipping Conditions Room Temperature
Storage Information Powder: -80°C, 2 years; -20°C, 1 years. In solvent: -80°C, 6 months; -20°C, 1 month